KATHERINE SLADEWSKI: Open Payments
NPI 1104481324 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 46 payments from 15 companies in 2025. Trend: 2023 $998 · 2024 $1,279 · 2025 $1,177
Food & beverage: $1,099Education: $78
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $342 |
| UROGEN PHARMA, INC. | 5 | $144 |
| Sumitomo Pharma America, Inc. | 5 | $119 |
| Dendreon Pharmaceuticals LLC | 4 | $104 |
| Astellas Pharma US Inc | 2 | $98 |
| Telix Pharmaceuticals | 2 | $53 |
| PFIZER INC. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 2 | $39 |
Products named: BOTOX, JELMYTO, PROVENGE, GEMTESA, XTANDI, ILLUCCIX, Nubeqa, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
